Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1965 Nov 13;93(20):1058–1064.

Agranulocytosis: A Report of 30 Cases

Harry M Pretty, Gilles Gosselin, Guy Colpron, L-A Long
PMCID: PMC1936473  PMID: 5843865

Abstract

Thirty cases of acute agranulocytosis, as defined by Schultz, were observed between 1946 and 1964 at the Hôtel-Dieu Hospital, Montreal. In 14 cases agents incriminated were: aminopyrine, phenylbutazone, sulfonamides and chlorpromazine. Aminopyrine alone was responsible for eight cases. In the remaining 16 cases no definite etiology was established. Clinical manifestations included fever, prostration, angina and multiple pharyngeal ulcerations; these were associated with severe leukopenia and agranulocytosis. The bone marrow showed hypoplasia, lymphocytosis and maturation arrest. Localized and pulmonary infections, pseudomembranous enterocolitis and septicemia were frequent complications in 21 cases and were usually responsible for death, which occurred in 12 cases. Almost all patients who developed septicemia or pseudomembranous enterocolitis died. The pathogenesis is still not clear, but chlorpromazine and its analogues may act as a metabolic inhibitor, while the aminopyrine group probably operates through an immune mechanism.

Full text

PDF
1058

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARORA Y. C. Agranulocytosis following acetazolamide therapy. N Y State J Med. 1959 Mar 15;59(6):1119–1120. [PubMed] [Google Scholar]
  2. BIRD C. E. Agranulocytosis due to imipramine (tofranil). Can Med Assoc J. 1960 May 14;82:1021–1022. [PMC free article] [PubMed] [Google Scholar]
  3. CARFAGNO S. C., MAGEE J. T. Granulocytopenia due to chlorpromazine: a report of 11 cases. Am J Med Sci. 1961 Jan;241:44–54. doi: 10.1097/00000441-196101000-00006. [DOI] [PubMed] [Google Scholar]
  4. FIORE J. M., NOONAN F. M. Agranulocytosis due to mepazine (phenothiazine); report of three cases. N Engl J Med. 1959 Feb 19;260(8):375–378. doi: 10.1056/NEJM195902192600806. [DOI] [PubMed] [Google Scholar]
  5. HOFFMAN F. G., ZIMMERMAN S. L., REESE J. D. Fatal agranulocytosis associated with acetazolamide. N Engl J Med. 1960 Feb 4;262:242–244. doi: 10.1056/NEJM196002042620508. [DOI] [PubMed] [Google Scholar]
  6. KARLIN H. Fatal agranulocytosis following chlorpropamide treatment of diabetes. Report of a case. N Engl J Med. 1960 May 26;262:1076–1077. doi: 10.1056/NEJM196005262622107. [DOI] [PubMed] [Google Scholar]
  7. KENNEDY R. D., HYNES J. Agranulocytosis due to oxyphen-butazone. Lancet. 1962 Nov 24;2(7265):1086–1086. doi: 10.1016/s0140-6736(62)90788-2. [DOI] [PubMed] [Google Scholar]
  8. KORST D. R. Agranulocytosis caused by phenothiazine derivatives. J Am Med Assoc. 1959 Aug 22;170(17):2076–2081. doi: 10.1001/jama.1959.03010170038009. [DOI] [PubMed] [Google Scholar]
  9. KOSZEWSKI B. J., HUBBARD T. F. Immunologic agranulocytosis due to mercurial diuretics. Am J Med. 1956 Jun;20(6):958–963. doi: 10.1016/0002-9343(56)90262-5. [DOI] [PubMed] [Google Scholar]
  10. MARCHAL G. [Prognosis of agranulocytosis and of pancytopenias]. Presse Med. 1959 Aug 8;67:1488–1490. [PubMed] [Google Scholar]
  11. MOESCHLIN S. Leukocyte-autoantibodies. Acta Haematol. 1958 Jul-Oct;20(1-4):167–178. doi: 10.1159/000205479. [DOI] [PubMed] [Google Scholar]
  12. MOESCHLIN S., WAGNER K. [Agranulocytosis due to the occurrence of leukocyte-agglutinins; pyramidon and cold agglutinins]. Acta Haematol. 1952 Jul-Aug;8(1-2):29–41. doi: 10.1159/000204146. [DOI] [PubMed] [Google Scholar]
  13. PISCIOTTA A. V., EBBE S., LENNON E. J., METZGER G. O., MADISON F. W. Agranulocytosis following administration of phenothiazine derivatives. Am J Med. 1958 Aug;25(2):210–223. doi: 10.1016/0002-9343(58)90027-5. [DOI] [PubMed] [Google Scholar]
  14. PISCIOTTA A. V., KALDAHL J. Studies on agranulocytosis. IV. Effects of chlorpromazine on nucleic acid synthesis of bone marrow cells in vitro. Blood. 1962 Sep;20:364–376. [PubMed] [Google Scholar]
  15. PISCIOTTA A. V., SANTOS A. S., KELLER C. STUDIES ON AGRANULOCYTOSIS. V. PATTERNS OF RECOVERY FROM DRUG-INDUCED BONE MARROW DAMAGE. J Lab Clin Med. 1964 Mar;63:445–458. [PubMed] [Google Scholar]
  16. PROUT B. J., EDWARDS E. A. AGRANULOCYTOSIS DURING ADMINISTRATION OF "ATROMID". Br Med J. 1963 Aug 31;2(5356):543–544. doi: 10.1136/bmj.2.5356.543. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. TASHJIAN A. H., Jr, LEDDY J. P. Agranulocytosis associated with phenindione: a case report with review of the literature. Arch Intern Med. 1960 Jan;105:121–125. doi: 10.1001/archinte.1960.00270130137018. [DOI] [PubMed] [Google Scholar]
  18. THIRKETTLE J. L., GOUGH K. R., READ A. E. Agranulocytosis associated with sulphasalazine ('Salazopyrin') therapy. Lancet. 1963 Jun 29;1(7296):1395–1397. doi: 10.1016/s0140-6736(63)92048-8. [DOI] [PubMed] [Google Scholar]
  19. WALZER R. A., EINBINDER J. Immunoleukopenia as an aspect of hypersensitivity to Propylthiouracil. JAMA. 1963 Jun 8;184:743–746. doi: 10.1001/jama.1963.03700230043006. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES